Bert Spenkelink

1.6k total citations
36 papers, 1.2k citations indexed

About

Bert Spenkelink is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Molecular Biology. According to data from OpenAlex, Bert Spenkelink has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Health, Toxicology and Mutagenesis, 10 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Bert Spenkelink's work include Carcinogens and Genotoxicity Assessment (10 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). Bert Spenkelink is often cited by papers focused on Carcinogens and Genotoxicity Assessment (10 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). Bert Spenkelink collaborates with scholars based in Netherlands, Thailand and Jordan. Bert Spenkelink's co-authors include Ivonne M.C.M. Rietjens, Ans Punt, Marelle G. Boersma, Jelmer J. van Zanden, Nicole H.P. Cnubben, Laura de Haan, G.M. Alink, Peter J. van Bladeren, Hester van der Woude and Hanem M. Awad and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Chemosphere.

In The Last Decade

Bert Spenkelink

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bert Spenkelink Netherlands	19	323	296	172	170	165	36	1.2k
Christine Hoelzl Austria	14	187 0.6×	330 1.1×	122 0.7×	202 1.2×	192 1.2×	16	1.0k
Juliana Mara Serpeloni Brazil	21	162 0.5×	326 1.1×	155 0.9×	110 0.6×	285 1.7×	60	996
Xiangyu Cao China	24	175 0.5×	656 2.2×	236 1.4×	168 1.0×	228 1.4×	63	1.6k
B. Danielewska-Nikiel Japan	8	117 0.4×	325 1.1×	223 1.3×	114 0.7×	166 1.0×	10	1.0k
Donatella Canistro Italy	22	176 0.5×	612 2.1×	184 1.1×	81 0.5×	316 1.9×	62	1.4k
G Vollmer Germany	7	281 0.9×	319 1.1×	137 0.8×	95 0.6×	140 0.8×	12	965
Gustavo Rafael Mazzaron Barcelos Brazil	22	556 1.7×	242 0.8×	109 0.6×	135 0.8×	194 1.2×	53	1.2k
Harold E. Seifried United States	16	169 0.5×	628 2.1×	323 1.9×	106 0.6×	207 1.3×	27	1.6k
Solomon E. Owumi Nigeria	27	277 0.9×	415 1.4×	137 0.8×	159 0.9×	550 3.3×	104	1.8k
Sung‐Hee Cho South Korea	20	163 0.5×	383 1.3×	71 0.4×	106 0.6×	120 0.7×	91	1.1k

Countries citing papers authored by Bert Spenkelink

Since Specialization

Citations

This map shows the geographic impact of Bert Spenkelink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Spenkelink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Spenkelink more than expected).

Fields of papers citing papers by Bert Spenkelink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert Spenkelink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Spenkelink. The network helps show where Bert Spenkelink may publish in the future.

Co-authorship network of co-authors of Bert Spenkelink

This figure shows the co-authorship network connecting the top 25 collaborators of Bert Spenkelink. A scholar is included among the top collaborators of Bert Spenkelink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert Spenkelink. Bert Spenkelink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rietjens, Ivonne M.C.M., et al.. (2024). Species specific kinetics of imidacloprid and carbendazim in mouse and rat and consequences for biomonitoring. Computational Toxicology. 32. 100334–100334.

Wesseling, Sebastiaan, et al.. (2021). Physiologically based kinetic modelling based prediction of in vivo rat and human acetylcholinesterase (AChE) inhibition upon exposure to diazinon. Archives of Toxicology. 95(5). 1573–1593. 12 indexed citations

Kulthong, Kornphimol, Loes P. M. Duivenvoorde, Huiyi Sun, et al.. (2020). Microfluidic chip for culturing intestinal epithelial cell layers: Characterization and comparison of drug transport between dynamic and static models. Toxicology in Vitro. 65. 104815–104815. 60 indexed citations

Haan, Laura de, et al.. (2020). Induction of peroxisome proliferator activated receptor γ (PPARγ) mediated gene expression and inhibition of induced nitric oxide production by Maerua subcordata (Gilg) DeWolf. BMC Complementary Medicine and Therapies. 20(1). 80–80. 10 indexed citations

Haan, Laura de, Bert Spenkelink, Sebastiaan Wesseling, et al.. (2019). Effects of Maerua subcordata (Gilg) DeWolf on electrophile-responsive element (EpRE)-mediated gene expression in vitro. PLoS ONE. 14(4). e0215155–e0215155. 3 indexed citations

Ning, Jia, Jochem Louisse, Bert Spenkelink, Sebastiaan Wesseling, & Ivonne M.C.M. Rietjens. (2017). Study on inter-ethnic human differences in bioactivation and detoxification of estragole using physiologically based kinetic modeling. Archives of Toxicology. 91(9). 3093–3108. 8 indexed citations

Spenkelink, Bert, et al.. (2017). Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity. Toxicological Sciences. 157(2). 365–376. 16 indexed citations

Spenkelink, Bert, et al.. (2016). Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols. Archives of Toxicology. 91(5). 2119–2133. 38 indexed citations

Spenkelink, Bert, et al.. (2014). Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations. Toxicology and Applied Pharmacology. 283(2). 117–126. 13 indexed citations

10.

Paini, Alicia, Ans Punt, Gabriele Scholz, et al.. (2012). In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling. Mutagenesis. 27(6). 653–663. 29 indexed citations

11.

Spenkelink, Bert, et al.. (2012). Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat. Toxicology and Applied Pharmacology. 260(3). 271–284. 38 indexed citations

12.

Woutersen, R.A., et al.. (2012). Relative embryotoxic potency of p-substituted phenols in the embryonic stem cell test (EST) and comparison to their toxic potency in vivo and in the whole embryo culture (WEC) assay. Toxicology Letters. 213(2). 235–242. 18 indexed citations

13.

Spenkelink, Bert, Marelle G. Boersma, Ans Punt, et al.. (2010). Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat. Toxicology in Vitro. 25(1). 267–285. 35 indexed citations

14.

Brand, Walter, Jia Shao, E.F. Hoek–van den Hil, et al.. (2010). Stereoselective Conjugation, Transport and Bioactivity ofS- andR-Hesperetin Enantiomers in Vitro. Journal of Agricultural and Food Chemistry. 58(10). 6119–6125. 42 indexed citations

15.

Spenkelink, Bert, Hans Mooibroek, Lolke Sijtsma, et al.. (2008). An n-3 PUFA-rich microalgal oil diet protects to a similar extent as a fish oil-rich diet against AOM-induced colonic aberrant crypt foci in F344 rats. Food and Chemical Toxicology. 47(2). 316–320. 27 indexed citations

16.

Schutte, Maaike E., G.M. Alink, Andreas P. Freidig, et al.. (2008). Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats. Food and Chemical Toxicology. 46(11). 3422–3428. 6 indexed citations

17.

Murk, Albertinka J., et al.. (1996). Monitoring exposure and effects of polyhalogeneted aromatic hydrocarbons (PHAHs) in European otters (Lutra lutra).. Socio-Environmental Systems Modeling. 29. 64–69. 3 indexed citations

18.

Hassing, Ine, et al.. (1995). Interactive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoids on proliferation and differentiation in cultured human keratinocytes: quantification of cross-linked envelope formation. Archives of Toxicology. 69(6). 368–378. 7 indexed citations

19.

Spenkelink, Bert, et al.. (1990). Cytotoxicity of S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine after apical and basolateral exposure of LLC-PK1 monolayers. Involvement of an amino acid transport system. Chemico-Biological Interactions. 75(1). 119–130. 8 indexed citations

20.

Spenkelink, Bert, et al.. (1988). Differential toxicity as a result of apical and basolateral treatment of LLC-PK1 monolayers with S-(1,2,3,4,4-pentachlorobutadienyl)glutathione and N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine. Chemico-Biological Interactions. 65(3). 283–293. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact